413 related articles for article (PubMed ID: 9115163)
1. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
[TBL] [Abstract][Full Text] [Related]
3. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.
Erben RG; Weiser H; Sinowatz F; Rambeck WA; Zucker H
Calcif Tissue Int; 1992 Mar; 50(3):228-36. PubMed ID: 1617497
[TBL] [Abstract][Full Text] [Related]
5. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
[TBL] [Abstract][Full Text] [Related]
6. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats.
Weber K; Kaschig C; Erben RG
Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
Erben RG; Bromm S; Stangassinger M
Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
[TBL] [Abstract][Full Text] [Related]
8. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
9. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Finch JL; Brown AJ; Slatopolsky E
J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
[TBL] [Abstract][Full Text] [Related]
11. Bone-resorbing activities of 24-epi-1 alpha-hydroxyvitamin D2 and 24-epi-1 alpha,25-dihydroxyvitamin D2.
Yokoyama K; Miyahara T; Matsumoto M; Hashimoto K; Komiyama H; Miyanishi A; Kotera N; Maruyama F; Kozuka H
Calcif Tissue Int; 1995 Jan; 56(1):49-53. PubMed ID: 7796346
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
14. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
[TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxy- and 1α,25-Dihydroxycholecalciferol Have Greater Potencies than 25-Hydroxy- and 1α,25-Dihydroxyergocalciferol in Modulating Cultured Human and Mouse Osteoblast Activities.
Zarei A; Hulley PA; Sabokbar A; Javaid MK; Morovat A
PLoS One; 2016; 11(11):e0165462. PubMed ID: 27893751
[TBL] [Abstract][Full Text] [Related]
16. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
Knutson JC; LeVan LW; Valliere CR; Bishop CW
Biochem Pharmacol; 1997 Mar; 53(6):829-37. PubMed ID: 9113104
[TBL] [Abstract][Full Text] [Related]
18. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
Erben RG; Bromm S; Stangassinger M
Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.
DeLuca HF; Sicinski RR; Tanaka Y; Stern PH; Smith CM
Am J Physiol; 1988 Apr; 254(4 Pt 1):E402-6. PubMed ID: 2833108
[TBL] [Abstract][Full Text] [Related]
20. Histomorphometric analysis of the rat proximal tibial metaphysis by "linear scanning".
Erben RG; Kohn B; Rambeck WA; Zucker H
Scanning Microsc; 1990 Sep; 4(3):625-38; discussion 638-40. PubMed ID: 2080427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
